Clay Thorp Phase Bio Pharmaceuticals Inc (PHAS) insider trading activity

PHAS Quotes by TradingView

Clay Thorp is Director of PhaseBio Pharmaceuticals Inc. Currently has a direct ownership of 36,693 shares of PHAS, which is worth approximately $0. The most recent transaction as insider was on May 19, 2023, when has been sold 3,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.7K
0% 3M change
0% 12M change
Total Value Held $0

Clay Thorp Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 19 2023
BUY
Exercise of conversion of derivative security
-
3,750 Added 9.27%
36,693 Common Stock
Aug 18 2021
BUY
Open market or private purchase
$30,000 $3.0 p/Share
10,000 Added 23.29%
32,943 Common Stock
Nov 24 2020
BUY
Open market or private purchase
$7,000 $3.5 p/Share
2,000 Added 8.02%
22,943 Common Stock
Nov 23 2020
BUY
Open market or private purchase
$11,010 $3.67 p/Share
3,000 Added 12.53%
20,943 Common Stock
Nov 16 2020
BUY
Other acquisition or disposition
-
2,144 Added 10.67%
17,943 Common Stock

Also insider at

CLSD
Clearside Biomedical, Inc. Healthcare
VIGL
Vigil Neuroscience, Inc. Healthcare
Director
CT

Clay Thorp

Director
Malvern, PA

Track Institutional and Insider Activities on PHAS

Follow PhaseBio Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHAS shares.

Notify only if

Insider Trading

Get notified when an Phase Bio Pharmaceuticals Inc insider buys or sells PHAS shares.

Notify only if

News

Receive news related to PhaseBio Pharmaceuticals Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PHAS